Sudhir Agrawal, PhD

Sudhir Agrawal, D. Phil, FRSC is a Visiting Professor in the Department of Medicine at The University of Massachusetts Medical School, a member of the Business Advisory Board of The Harvard Medical School’s Initiative for RNA Medicine, and a member of advisory board of Lytix biopharma. He is founder and member of Arnay Sciences LLC. He is also a founder of Idera Pharmaceuticals and had held various leadership roles within the company, including Chairman, CEO, President of Research, and Chief Scientific Officer. Sudhir’s research interests focus on the discovery and development of nucleic acid therapeutics, including antisense oligonucleotides (ASOs). He has edited four books on oligonucleotides and antisense technology, published hundreds of research papers on these topics, and is listed as a co-inventor of more than 400 patents worldwide.